Covid-19 Stalls Clinical Trials for Everything but Covid-19

Doctors cut out part of her lung. They delivered radiation, immunotherapy, and chemotherapy. But Rose Fraenza’s stage 4 lung cancer proved to be stubborn. In search of a new treatment, her doctors’ testing zeroed in on ulixertinib, an experimental drug designed to strike at genetic changes in her tumor. She volunteered for a clinical trial at Smilow Cancer Hospital, the clinical arm of Yale Cancer Center, to try ulixertinib. In March, doctors planned to enroll Fraenza. Then came Covid-19. The pandemic put the study on hold, with no timeline in…

Read More